MCD
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| NEPTUNE Match Study (NCT04571658) | University of Michigan | 2022-05-02 |
| Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease (NCT04009668) | University of Michigan | 2019-10-02 |
Track MCD automatically
Every clearance here is in the API, with alerts when new ones post.